financetom
Business
financetom
/
Business
/
Zura Bio Insider Bought Shares Worth $496,000, According to a Recent SEC Filing
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Zura Bio Insider Bought Shares Worth $496,000, According to a Recent SEC Filing
May 23, 2024 7:23 AM

10:00 AM EDT, 05/23/2024 (MT Newswires) -- Arnout Ploos van Amstel, Director, on May 17, 2024, executed a purchase for 80,000 shares in Zura Bio ( ZURA ) for $496,000. Following the Form 4 filing with the SEC, van Amstel has control over a total of 100,000 shares of the company, with 100,000 shares held directly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/1855644/000141588924014179/xslF345X03/form4-05232024_120531.xml

Price: 5.76, Change: +0.24, Percent Change: +4.37

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
US safety board to hold hearings on Boeing 737 MAX door incident
US safety board to hold hearings on Boeing 737 MAX door incident
Jul 17, 2024
WASHINGTON, July 17 (Reuters) - The National Transportation Safety Board said on Wednesday it had scheduled 20 hours of hearings over two days on the January Alaska Airlines Boeing 737 MAX 9 in-flight door plug emergency and would review oversight by U.S. safety regulators. The NTSB said on its website the Aug. 6-7 hearings are set to last 10 hours...
RBC on Business Jet Market Outlook
RBC on Business Jet Market Outlook
Jul 17, 2024
02:21 PM EDT, 07/17/2024 (MT Newswires) -- RBC's analysis of the business jet market increases its conviction in the long-term demand trends and upside avenues in aftermarket services for leading OEMs. The business jet fleet is the oldest in over two decades, supporting demand for new jets and planned production rate increases. With used inventory levels remaining significantly below the...
Cassava Sciences Faces Leadership Shake-Up, Prioritizes Transparency And Scientific Rigor In Alzheimer's Trials
Cassava Sciences Faces Leadership Shake-Up, Prioritizes Transparency And Scientific Rigor In Alzheimer's Trials
Jul 17, 2024
Cassava Sciences Inc ( SAVA ) stock is trading lower on Wednesday on a heavy session volume of 14.35 million, as per data from Benzinga Pro. The Board of Directors appointed Richard (Rick) Barry as Executive Chairman and the company’s principal executive officer, effective immediately. The company is searching for a new permanent CEO. Mr. Barry succeeds Remi Barbier, the...
4D Molecular Therapeutics Goes Neck To Neck With Rival, Shares New Phase 2 Data For Its Wet AMD Candidate
4D Molecular Therapeutics Goes Neck To Neck With Rival, Shares New Phase 2 Data For Its Wet AMD Candidate
Jul 17, 2024
Wednesday, 4D Molecular Therapeutics, Inc. ( FDMT )unveiled interim 24-week data from the Population Extension cohort of its PRISM Phase 2 Clinical Trial. The trial evaluates intravitreal 4D-150 in a broad wet AMD patient population. Also Read: Why Is 4D Molecular Therapeutics Stock Trading Lower On Thursday? Genetic Disease-Focused Study Data Released. The findings were presented at the American Society...
Copyright 2023-2026 - www.financetom.com All Rights Reserved